Page last updated: 2024-08-21

isoxazoles and Atherosclerosis

isoxazoles has been researched along with Atherosclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bot, I; Kritikou, E; Kröner, MJ; Kuiper, J; Schaftenaar, FH; Swart, M; van der Heijden, T; van Puijvelde, GH; van Santbrink, PJ1
Eggertsen, G; Gåfvels, M; Jiang, ZY; Kannisto, K; Ovchinnikova, O; Parini, P; Paulsson-Berne, G; Slätis, K1
Barter, PJ; Beattie, DT; Bursill, CA; Castro, ML; Heather, AK; Nakhla, S; Rye, KA; van der Vorst, E1
Baldelli, F; Cipriani, S; D'Amore, C; Fiorucci, S; Francisci, D; Mencarelli, A; Renga, B; Schiaroli, E1
Boettcher, A; Burnet, M; Deuschle, U; Hahn, U; Hambruch, E; Kinzel, O; Kremoser, C; Krol, HD; Levi, M; Matysik, S; Miyazaki, M; Miyazaki-Anzai, S; Perović-Ottstadt, S; Schlüter, T; Schmitz, G1
Bruno, A; Di Vito, C; Emanuele, E; Minoretti, P1

Other Studies

6 other study(ies) available for isoxazoles and Atherosclerosis

ArticleYear
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice.
    Scientific reports, 2016, 11-24, Volume: 6

    Topics: Animals; Atherosclerosis; Cholesterol, LDL; Disease Models, Animal; Endocytosis; Humans; Isoxazoles; Lysophospholipids; Mice; Propionates; Receptors, LDL; Receptors, Lysophosphatidic Acid; Signal Transduction

2016
Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.
    Journal of lipid research, 2010, Volume: 51, Issue:11

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Bile; Cholesterol; Cholic Acids; Gene Knockout Techniques; Intestinal Absorption; Isoxazoles; Liver; Mice; Micelles; Receptors, Cytoplasmic and Nuclear

2010
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:9

    Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokine CX3CL1; Chemokines; Chemotaxis, Leukocyte; Disease Models, Animal; Down-Regulation; Endothelial Cells; Humans; I-kappa B Proteins; Injections, Intravenous; Isoxazoles; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NF-KappaB Inhibitor alpha; Phosphorylation; PPAR gamma; Receptors, CCR2; Receptors, Chemokine; Receptors, Interleukin-8A; RNA, Messenger; Sulfones; Transcription Factor RelA

2010
The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Atherosclerosis; Cell Line; Cell Separation; gag Gene Products, Human Immunodeficiency Virus; Gene Expression Regulation; GTP-Binding Proteins; HIV Antigens; HIV Infections; HIV-1; Humans; Inflammation; Isoxazoles; Janus Kinases; Lipid Metabolism; Lipopolysaccharide Receptors; Macrophages; Monocytes; Neoplasm Proteins; Neutralization Tests; Phenotype; Phosphorylation; PPAR gamma; Receptors for Activated C Kinase; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; Thiazolidinediones; Vaccination; Vidarabine

2012
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:3

    Topics: Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Benzoates; Biological Transport; Cholesterol; Cholesterol Ester Transfer Proteins; Diet, High-Fat; Disease Models, Animal; Feces; Female; Humans; Isoxazoles; Lipoproteins, HDL; Liver; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Species Specificity; Structure-Activity Relationship

2012
Leflunomide as an antiatherogenic drug.
    Medical hypotheses, 2007, Volume: 68, Issue:5

    Topics: Antigen-Presenting Cells; Antirheumatic Agents; Atherosclerosis; Chemotaxis; Dendritic Cells; Humans; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Models, Cardiovascular; NF-kappa B; Signal Transduction

2007